Overview
This benchmark is directly usable for evaluating Chinese medical LLMs; baselines and code are provided. Results are strong evidence that PEFT fine-tuning helps, but adaptation to your product still needs task-specific tuning and clinical validation.
Citations4
Evidence Strength0.80
Confidence0.80
Risk Signals8
Trust Signals
Findings with numeric evidence: 5/5
Findings with evidence refs: 5/5
Results with explicit delta: 1/4
Reproducibility
Status: Code + data available
Open source: Partial
At A Glance
Cost impact: 60%
Production readiness: 60%
Novelty: 45%
Why It Matters For Business
PromptCBLUE gives a practical, Chinese-language testbed for medical LLM products. It shows that inexpensive PEFT fine-tuning of open 13B models can beat few-shot API use, so companies can invest in targeted fine-tuning to improve medical features.
Who Should Care
Summary TLDR
The authors convert the Chinese CBLUE medical NLP benchmark into PromptCBLUE: a prompt/instruction-format, multi-task testbed for Chinese medical LLMs. PromptCBLUE covers entity extraction, classification, inference, dialogue symptom/status tasks and generation. They provide human‑validated prompt templates, limit per-task splits for LLM training, host an online leaderboard, release code, and report baselines: few-shot API results (GPT-4 ≈0.518 overall) and many PEFT fine-tuning runs where open-source 13B models (Baichuan-13B with LoRA) reach ≈0.71 overall. Key takeaways: prompt format + PEFT fine-tuning matter; LoRA is a strong PEFT choice; medical-only pretraining alone did not clearly out
Problem Statement
Existing biomedical benchmarks are mostly English, not in instruction/prompt form, and some test sets leaked into LLM pretraining. That makes it hard to evaluate Chinese LLMs on practical multi-task medical text processing and to compare prompt-based/fine-tuning methods.
Main Contribution
Built PromptCBLUE: a prompt-format, multi-task Chinese medical benchmark derived from CBLUE.
Created and expert-validated prompt template pool (manual + ChatGPT paraphrases).
Key Findings
Fine-tuned open-source 13B models outperform few-shot commercial APIs on PromptCBLUE.
Among PEFT methods tested, LoRA gave the highest average score under large-scale fine-tuning.
Results
| Metric | Value | Baseline | Delta | Split / Dataset | Evidence | Evidence Ref |
|---|---|---|---|---|---|---|
| Overall score (few-shot) | GPT-4 0.518 | — | — | PromptCBLUE test set | Table 1 overall score for GPT-4 under few-shot in-context learning | Table 1 |
| Overall score (PEFT fine-tuned) | Baichuan-13B (LoRA) 0.71 | GPT-4 few-shot 0.518 | +0.192 | PromptCBLUE test set | Table 3 reports Baichuan-13B LoRA overall score 0.71; paper compares to GPT-4 few-shot | Table 3, Table 1 |
What To Try In 7 Days
Run LoRA fine-tuning on a 13B open model (Baichuan-13B or LLaMA-2-13B) using a small task subset from PromptCBLUE.
Adopt the paper's prompt templates and test both plain prompts and formats with explicit output specs.
Add 50–200 labeled examples per target task and compare few-shot vs PEFT fine-tuned performance using the benchmark scripts in the repo.
Optimization Features
Model Optimization
Training Optimization
Reproducibility
Risks & Boundaries
Limitations
Benchmark focuses on Chinese and CBLUE-derived tasks; not a full clinical QA or decision-support test.
Some tasks require structured post-processing (regex extraction) which may bias results.
When Not To Use
Not suitable as a clinical safety or regulatory validation dataset without extra clinical audit.
Not a replacement for English or multi-lingual medical benchmarks when cross-lingual claims are needed.
Failure Modes
LLMs omit entities or predict wrong entity spans in extraction tasks (paper reports omissions and boundary errors).
Models misclassify 'not-in-list' / 'other' labels frequently.